B
Biosynthetic Technologies
Manufactures a revolutionary new class of synthetic oils made from organic fatty acids found in plant oils
About Biosynthetic Technologies
Biosynthetic Technologies specializes in the production of biobased synthetic compounds known as estolides, derived from organic fatty acids found in various bio-derived oils. These compounds are designed to meet the evolving needs of the Beauty and Personal Care industry, as well as applications in lubricants, automotive, marine, and industrial sectors. The company operates in the sustainable manufacturing market, emphasizing environmental responsibility by minimizing negative impacts and conserving natural resources. Biosynthetic Technologies serves a diverse range of clients, including manufacturers in the personal care, automotive, and industrial sectors. The business model revolves around the production and sale of high-performance, biodegradable, and renewable estolides, generating revenue through direct sales and partnerships. The company's commitment to sustainability and innovation positions it as a leader in the biobased synthetic compounds market.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2006
- Headquarters
- Irvine, United States
- Employees
- 11
- Open positions
- None listed
- Dealroom signal
- 45.1/100
- Industry
- Health
- Sub-industry
- Oil & Gas, BioTechnology
- Sector
- Biotech & Life Sciences, Personal Health, Organic, Biotechnology, Oil & Gas, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b, b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Feb 2022 | $7.5M | $48M | HG Ventures | ↗ |
| SERIES A✓Equity / VC | May 2019 | $9.5M | $38M | HG Ventures | — |
Growth signals
Latest recorded traffic for Biosynthetic Technologies is 1.2K monthly website visits, up 48.1% over the last three months. Biosynthetic Technologies's team declined 26.7% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Evonik Venture Capital
BP Ventures
HG Ventures
Series B and later1 investor entered at this stage
US Department of Agriculture
Other known investors1 additional known investor
Calumet
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Biosynthetic Technologies on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Biosynthetic Technologies’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.